论文信息 - Bortezomib and panobinostat combination is effective against PTCL. - 字舞流文

Bortezomib and panobinostat combination is effective against PTCL.

D. Tan | Ai Leen Ang | Y. Goh | C. Phipps | Swee Jin Mok

[1] L. Gordon,et al. Histone Deacetylase Inhibitor (HDACi) PCI-24781 and Bortezomib Result in Synergistic Apoptosis in Hodgkin Lymphoma (HL) and Non-Hodgkin’s Lymphoma (NHL) Cell Lines: Investigation of Cell Death and NFKB-Mediated Pathways. , 2007 .

[2] K. Anderson,et al. Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells. , 2006, Blood.

[3] S. Schreiber,et al. Small-molecule inhibition of proteasome and aggresome function induces synergistic antitumor activity in multiple myeloma. , 2005, Proceedings of the National Academy of Sciences of the United States of America.